Syra Health Corp. SYRA

Q3 FY2026 · ended Sep 30, 2026 · Revenue $2.56M, +51.5% YoY · Filed Nov 3, 2026

Syra Health Corp. (SYRA) files with the SEC under industry code 7361, Services-Employment Agencies. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $2.6 million and net income of $344,610. As of Sep 30, 2026 it held $2.4 million in cash and investments and $57,010 in total debt.

Revenue
$2.56M
+51.5% vs year-ago quarter
Net income
$344,610
+252.5% vs year-ago quarter
Operating cash flow
$331,840
+235.8% vs year-ago quarter
Free cash flow
$-300,196
EPS
$0.02
+200.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
13.85M
+22.1% vs year-ago quarter
Net cash
$2.33M
Q3 FY2026
Operating margin
6.8%
TTM

Company profile

Industry
Services-Employment Agencies (SIC 7361)
Listed as
SYRA (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carmel, IN
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1922335

Other Services-Employment Agencies companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Revenue
$2.6M
$2.4M
$2.3M
$1.7M
$1.7M
Operating income
$300,002
$251,571
$190,983
-$135,661
-$232,171
Net income
$344,610
$250,242
$240,979
-$134,570
-$225,902
Diluted EPS
$0.02
$0.02
$0.02
-$0.01
-$0.02
Operating cash flow
$331,840
-$718,762
$1.4M
-$289,192
-$244,308
Free cash flow
—
—
—
-$300,196
—
Total assets
$4.2M
$3.8M
$3.9M
$2.8M
$3.3M
Total liabilities
$1.2M
$1.2M
$1.6M
$674,739
$1.1M
Stockholders' equity
$3.0M
$2.6M
$2.4M
$2.1M
$2.2M
Cash and investments
$2.4M
$2.1M
$2.9M
$1.6M
$2.0M
Total debt
$57,010
$77,644
$11,060
$27,401
$43,450

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 11, 2026 Aug 11, 2026
8-K Current report
Shareholder vote results
Jul 23, 2026 Jul 23, 2026
ARS Annual report to shareholders Jun 1, 2026 Dec 31, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.